THE HEART OF AFIB:
RISK, PREVENTION, AND TREATMENT
Virtual Event Overview
During the pandemic, your heart care remains essential. Tune into this virtual event recording to learn about atrial fibrillation (AFib), including the mechanics of AFib, what you can do to reduce your risk, and the therapies available to you. Stanford Medicine is pioneering AFib treatment, translating the latest medical research into precise and minimally invasive therapies.
AFib is the most common irregular heart rhythm, with about 1 in 4 Americans expected to develop the condition in their lifetime. It can cause heart palpitations and fatigue, and increase your risk of stroke, heart failure, and death. If treated properly, however, individuals diagnosed with AFib can expect a good quality of life and normal lifespan. AFib is also preventable and symptoms can improve with lifestyle changes like weight loss, exercise, and a better diet.
This is a recording of a February 6, 2021 virtual event. The chat feature is no longer available.
Paul J. Wang, MD
Director, Cardiac Arrhythmia Service
Professor, Stanford University School of Medicine
Dr. Paul Wang is an expert in the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, ventricular arrhythmias, supraventricular arrhythmias, and sudden cardiac death. He was a co-inventor of catheter cryoablation, which has been used to treat over 250,000 patients with atrial fibrillation. He has practiced cardiac electrophysiology as an arrhythmia expert for over 26 years.
Melissa S. Burroughs, MD, MS, FACC
Dr. Melissa S. Burroughs is an expert in preventive cardiology and advanced echocardiography. She takes a holistic approach to the management of cardiovascular disease, applying the latest medical research to individualized patient-centered care. Dr. Burroughs has a special interest in global public health and has practiced in Latin America. She has more than 12 years of experience.
Anurag Gupta, MD, FACC
Anson Lee, MD
Assistant Professor, Stanford University School of Medicine
James Longoria, MD
Associate Professor, Stanford University School of Medicine
Dr. James Longoria is an expert in all facets of complex adult cardiothoracic surgical procedures and a nationally recognized expert in the minimally invasive surgical treatment of atrial fibrillation. He was issued a method patent for developing the TTMaze (Totally Thoracoscopic) procedure, along with other patents for specialized methods to treat cardiac arrhythmias. He has more than 20 years of experience.